Blood pressure
High blood pressure is a major cause of premature death worldwide, with an estimated 1.4 billion adults aged 30-79 years worldwide affected in 2024, representing 33 percent of the population in this age range. According to the World Health Organisation, hypertension occurs when the pressure in your blood vessels
Blood pressure
High blood pressure is a major cause of premature death worldwide, with an estimated 1.4 billion adults aged 30-79 years worldwide affected in 2024, representing 33 percent of the population in this age range. According to the World Health Organisation, hypertension occurs when the pressure in your blood vessels
Blood pressure
High blood pressure is a major cause of premature death worldwide, with an estimated 1.4 billion adults aged 30-79 years worldwide affected in 2024, representing 33 percent of the population in this age range. According to the World Health Organisation, hypertension occurs when the pressure in your blood vessels
Blood pressure
High blood pressure is a major cause of premature death worldwide, with an estimated 1.4 billion adults aged 30-79 years worldwide affected in 2024, representing 33 percent of the population in this age range. According to the World Health Organisation, hypertension occurs when the pressure in your blood vessels
Blood pressure
High blood pressure is a major cause of premature death worldwide, with an estimated 1.4 billion adults aged 30-79 years worldwide affected in 2024, representing 33 percent of the population in this age range. According to the World Health Organisation, hypertension occurs when the pressure in your blood vessels
Blood pressure
High blood pressure is a major cause of premature death worldwide, with an estimated 1.4 billion adults aged 30-79 years worldwide affected in 2024, representing 33 percent of the population in this age range. According to the World Health Organisation, hypertension occurs when the pressure in your blood vessels
Biochemistry
Research from McGill University has demonstrated that glucagon-like peptide-1 receptor agonists (GLP-1 RAs) produce modest reductions in blood pressure among individuals with type 2 diabetes and obesity. According to the study, these reductions appear to be driven primarily by weight loss, with additional contributions from potential weight-independent mechanisms such as
Biochemistry
Research from McGill University has demonstrated that glucagon-like peptide-1 receptor agonists (GLP-1 RAs) produce modest reductions in blood pressure among individuals with type 2 diabetes and obesity. According to the study, these reductions appear to be driven primarily by weight loss, with additional contributions from potential weight-independent mechanisms such as
Blood pressure
Researchers at the Guangdong Women and Children Hospital in Guangzhou, People's Republic of China, conducted a study to investigate the relationship between the triglyceride-glucose (TyG) index and blood pressure in children and adolescents. The study, published in High Blood Pressure & Cardiovascular Prevention, aimed to explore the mediating
Blood pressure
A recent study on cardiovascular research has highlighted the importance of considering cardiorespiratory fitness when interpreting exercise-induced systolic blood pressure (SBP) responses. The research, conducted by a team at the University of Tasmania, aimed to determine the relationship between exercise SBP, corrected and uncorrected for fitness, and abnormalities of cardiac
Blood pressure
As a leading cardiovascular surgeon, Dr. Jeremy London emphasizes the importance of incorporating aerobic exercise into one's daily routine to retrain the vascular system, lower blood pressure, and improve overall cardiovascular health. Through consistent aerobic exercise, the heart becomes more efficient at pumping blood, and the risk of
Blood pressure
A recent study on glaucoma published in the journal Ophthalmology Glaucoma has revealed that lower blood pressure is associated with faster progression of glaucomatous visual field loss. Researchers at the University of Miami Miller School of Medicine conducted a prospective cohort study involving 124 eyes of 63 subjects with glaucoma
